GGrantIndex
← Leaderboards

Arup Das

Albuquerque Va Medical Center

$7,242,993
Attributed
$7,242,993
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $666.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,242,993 · 4
VA$0 · 2

By mechanism

R01$7,242,993 · 3
I01$0 · 2
M01$0 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Vascular Endothelial Growth Factors

Research focus

Vascular Endothelial Growth FactorsPreventRetinaBlindnessAdultMolecularDiabetic RetinopathyVisionPlayBaseAngiogenesisResponseEndothelial CellsBlood VesselsLeadMacular EdemaMiddle AgeTherapeutic TargetDiabeticPathway InteractionsDiabetes MellitusEpidemicCellsEvent

Grant awards (31)

Microglia-Vascular Interaction in Alteration of Blood-Retinal Barrier in Diabetic Retinopathy$0
I01 · FY2025 · VA · contact PI
Microglia-Vascular Interaction in Alteration of Blood-Retinal Barrier in Diabetic Retinopathy$0
I01 · FY2024 · VA · contact PI
Microglia-Vascular Interaction in Alteration of Blood-Retinal Barrier in Diabetic Retinopathy$0
I01 · FY2023 · VA · contact PI
Novel Biomarkers and Genetics of Diabetic Retinopathy$467,370
R01 · FY2022 · EY · contact PI
Microglia-Vascular Interaction in Alteration of Blood-Retinal Barrier in Diabetic Retinopathy$0
I01 · FY2022 · VA · contact PI
Novel Biomarkers and Genetics of Diabetic Retinopathy$610,716
R01 · FY2021 · EY · contact PI
Novel Biomarkers and Genetics of Diabetic Retinopathy$666,571
R01 · FY2020 · EY · contact PI
Novel Biomarkers and Genetics of Diabetic Retinopathy$535,606
R01 · FY2019 · EY · contact PI
Novel Biomarkers and Genetics of Diabetic Retinopathy$512,760
R01 · FY2018 · EY · contact PI
Inflammatory Chemokines: A Novel Target in Early Diabetic Retinopathy$369,950
R01 · FY2015 · EY · contact PI
Sphingosine 1-Phosphate: A New Target for Early Diabetic Retinopathy$0
I01 · FY2015 · VA · contact PI
Inflammatory Chemokines: A Novel Target in Early Diabetic Retinopathy$369,950
R01 · FY2014 · EY · contact PI
Sphingosine 1-Phosphate: A New Target for Early Diabetic Retinopathy$0
I01 · FY2014 · VA · contact PI
Inflammatory Chemokines: A Novel Target in Early Diabetic Retinopathy$377,500
R01 · FY2013 · EY · contact PI
Sphingosine 1-Phosphate: A New Target for Early Diabetic Retinopathy$0
I01 · FY2013 · VA · contact PI
Extracellular Proteinases in Ocular Neovascularization$324,435
R01 · FY2010 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$327,713
R01 · FY2009 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$274,999
R01 · FY2009 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$321,159
R01 · FY2008 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$327,713
R01 · FY2007 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$337,500
R01 · FY2006 · EY · contact PI
Extracellular Proteinases in Ocular Neovascularization$300,000
R01 · FY2005 · EY
Extracellular Proteinases in Ocular Neovascularization$300,000
R01 · FY2004 · EY
Extracellular Proteinases in Ocular Neovascularization$300,000
R01 · FY2003 · EY
Extracellular Proteinases in Ocular Neovascularization$41,391
R01 · FY2003 · EY
Extracellular Proteinases in Ocular Neovascularization$300,000
R01 · FY2002 · EY
IDENTIFICATION OF SERUM MMP-9 IN ROP INFANTS$0
M01 · FY2002 · RR
IDENTIFICATION OF SERUM MMP-9 IN ROP INFANTS$0
M01 · FY2001 · RR
EXTRACELLULAR PROTEINASES IN RETINAL NEOVASCULARIZATION$177,660
R01 · FY2000 · EY
IDENTIFICATION OF SERUM MMP-9 IN ROP INFANTS$0
M01 · FY2000 · RR
IDENTIFICATION OF SERUM MMP-9 IN ROP INFANTS$0
M01 · FY2000 · RR